30 likes | 32 Vues
The Indian API market is estimated to witness a growth rate of over 9.5% during the forecast period. India is one of the emerging economies globally and a major player in the global API market. Rising prevalence of chronic diseases such as cancer and cardiovascular diseases (CVDs), presence of several medium to large API manufacturers, and increasing focus of government on the development of pharmaceutical manufacturing sector are some of the factors that are boosting the countryu2019s API market.
E N D
Orion Market Research Indian API Market, Size, Share, Analysis Report & Forecast to 2025 Request a Free Sample of our Indian API Market: https://www.omrglobal.com/request- sample/indian-api-market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404
The Indian API market is estimated to witness a growth rate of over 9.5% during the forecast period. India is one of the emerging economies globally and a major player in the global API market. Rising prevalence of chronic diseases such as cancer and cardiovascular diseases (CVDs), presence of several medium to large API manufacturers, and increasing focus of government on the development of pharmaceutical manufacturing sector are some of the factors that are boosting the country’s API market. As per the government of Uttarakhand, India has a market share of 20% in the global generic market by volume and has a network of more than 10,500 manufacturers and 3,000 pharma companies. The Indian pharmaceutical market has increased by 7.4 % and reached around $19.0 billion in 2017 and expected to reach nearly $29.0 billion in 2022. A full Report of Indian API Market is Available at: https://www.omrglobal.com/industry- reports/indian-api-market The Indian API market is segmented on the basis of type, type of synthesis, manufacturer type, therapeutics, and region. On the basis of type, the market is divided into a generic API and branded API. The branded API segment is estimated to be the dominant segment over the forecast period. On the basis of the type of synthesis, the market is classified into biotech API, synthetic API, and others. The synthetic API segment held the dominant position in the Indian API market in 2018. Furthermore, the market is classified on the basis of therapeutics into cardiovascular drugs, oncology drugs, neurology drugs, Non-steroidal Anti-inflammatory Drugs (NSAIDs), and others. Request a Free Sample of our Indian API Market: https://www.omrglobal.com/request- sample/indian-api-market India APIMarket Segmentation By Type •General API •Branded API By Type of Synthesis •Biotech API •Synthetic API •Others (High Potency API) By Therapeutics •Cardiovascular Drugs •Oncology Drugs •Neurology Drugs •Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
•Others (Orthopedic Drugs) Company Profiles •AbbVie Inc. •Aesica Pharmaceuticals, Ltd. •Almac group PLC •Aurobindo Pharma •Boehringer Ingelheim International GmbH •Cipla Ltd. •Dr. Reddy’s Laboratories Ltd. •GlaxoSmithKline PLC •Novartis International AG •Piramal Enterprises Ltd. •Sanofi SA •Siegfried Holding AG •Sun Pharmaceutical Industries Ltd. •Teva Pharmaceutical Industries Ltd. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/indian-api-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404